LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | (Q3)Sep 30, 2020 | (Q2)Jun 30, 2020 | (Q1)Mar 31, 2020 | (FY)Dec 31, 2019 | (Q4)Dec 31, 2019 | (Q3)Sep 30, 2019 | (Q2)Jun 30, 2019 | (Q1)Mar 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 99.87%-49K | -591.06%-4.78M | 47.99%7.15M | 105.03%346K | 92.28%-2.77M | -256.85%-36.91M | -88.04%973K | 136.88%4.83M | -59.95%-6.88M | -302.94%-35.84M |
Net income from continuing operations | -138.03%-96.11M | 62.41%-2.82M | 121.13%5.88M | -1.63%-1.87M | -2,910.67%-97.31M | -237.54%-40.38M | -55.18%-7.49M | -216.50%-27.82M | -193.72%-1.84M | -963.16%-3.23M |
Operating gains losses | -214.77%-1.49M | -229.07%-283K | -2,034.59%-3.58M | -158.30%-509K | 777.74%2.88M | -82.28%1.3M | -185.15%-86K | 58.12%185K | -55.80%873K | -93.62%328K |
Depreciation and amortization | 127.37%25.43M | -10.28%3.54M | 171.24%6.44M | 167.84%6.48M | 267.38%8.96M | 308.47%11.18M | 328.88%3.95M | 301.18%2.38M | 658.31%2.42M | 169.32%2.44M |
Deferred tax | 93.84%-3.24M | -325.02%-4.62M | 117.34%1.27M | 131.03%1.6M | 96.19%-1.49M | -4,078.65%-52.65M | -119.46%-1.09M | 11.96%-7.33M | -434.40%-5.14M | -73,649.06%-39.09M |
Other non cash items | 50.29%9.59M | 176.07%4.63M | 18.84%1.72M | -10.46%1.73M | 14.11%1.51M | 42.40%6.38M | 25.45%1.68M | 15.37%1.45M | 104.34%1.93M | 40.36%1.33M |
Change In working capital | -972.45%-19.89M | -326.76%-4.82M | -1,621.89%-2.57M | -21.93%-6.99M | -448.70%-5.51M | -1,112.42%-1.86M | -35.40%2.13M | -6.63%169K | 51.45%-5.73M | -80.67%1.58M |
-Change in receivables | -153.01%-3.19M | -37.00%407K | -81.99%325K | -2,852.50%-4.72M | -78.63%798K | 219.80%6.03M | 177.09%646K | 176.42%1.81M | 98.11%-160K | -64.53%3.73M |
-Change in prepaid assets | 45.63%2.23M | 141.80%3.89M | -108.71%-101K | -82.56%-471K | -11.15%-1.09M | 130.43%1.53M | -28.98%1.61M | 139.52%1.16M | 91.79%-258K | 20.55%-978K |
-Change in payables and accrued expense | -313.75%-6.61M | -218.65%-5.59M | 67.09%792K | 142.21%1.16M | -559.75%-2.97M | 44.82%3.09M | 18.20%4.71M | -78.67%474K | -43.62%-2.74M | 129.84%646K |
-Change in other current liabilities | 7.02%-7.15M | 42.82%-1.88M | -65.98%-2.41M | -2.73%-1.47M | 8.47%-1.4M | -198.15%-7.69M | -853.78%-3.28M | -137.60%-1.45M | -145.68%-1.43M | -227.62%-1.53M |
-Change in other working capital | -7.46%-5.17M | -6.55%-1.66M | 35.04%-1.18M | -28.87%-1.48M | -196.17%-850K | 30.89%-4.82M | 12.38%-1.56M | 49.60%-1.82M | 19.18%-1.15M | -86.36%-287K |
Cash from discontinued investing activities | -89.25%4.33M | 118.86%427K | -98.55%10K | 97.26%-96K | -91.20%3.99M | 330.55%40.32M | -148.65%-2.26M | -48.63%692K | -3.51M | 45.4M |
Operating cash flow | 25.77%4.29M | -237.03%-4.35M | 29.63%7.16M | 102.41%250K | -87.16%1.23M | -89.64%3.41M | -110.09%-1.29M | 63.08%5.52M | -1,009.51%-10.39M | -45.86%9.56M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -95.26%7.87M | 685.47%3.19M | 12,170.97%3.74M | -99.42%964K | 32.43%-25K | 180,736.96%166.19M | 277.29%406K | 91.73%-31K | 6,954.36%165.85M | 97.99%-37K |
Net PPE purchase and sale | -14.06%-73K | --0 | -6,700.00%-68K | --0 | 54.55%-5K | 98.48%-64K | 90.53%-16K | 99.68%-1K | 98.14%-36K | 99.39%-11K |
Net intangibles purchase and sale | 5,940.44%7.94M | 8,958.33%3.19M | 12,800.00%3.81M | 2,290.91%964K | 23.08%-20K | -103.30%-136K | 40.00%-36K | 50.00%-30K | -101.03%-44K | 44.68%-26K |
Net business purchase and sale | --0 | --0 | --0 | ---- | ---- | --165.93M | --0 | --0 | ---- | ---- |
Net investment purchase and sale | --0 | ---- | ---- | ---- | ---- | --458K | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -95.26%7.87M | 685.47%3.19M | 12,170.97%3.74M | -99.42%964K | 66.67%-25K | 96,694.19%166.14M | 253.21%406K | 91.95%-31K | 7,057.62%165.84M | 95.92%-75K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 97.19%-4.96M | -237.28%-5.57M | 41.70%-5.43M | 101.35%2.21M | 145.93%3.83M | -419.67%-176.81M | 148.05%4.06M | -119.83%-9.31M | -1,460.77%-163.21M | 23.42%-8.34M |
Net issuance payments of debt | 102.04%3.4M | -143.85%-2.85M | 2.00%-4.9M | 103.27%5.27M | 183.14%5.88M | -1,592.16%-166.66M | 191.87%6.5M | -141.73%-5M | -1,997.20%-161.09M | 0.00%-7.08M |
Net common stock issuance | 71.69%-77K | -50.00%-36K | --0 | 93.59%-5K | 78.82%-36K | 88.79%-272K | -166.67%-24K | --0 | 6.02%-78K | 91.14%-170K |
Net other financing activities | 16.08%-8.29M | -10.83%-2.68M | 87.71%-530K | -49.41%-3.06M | -84.45%-2.02M | 54.60%-9.87M | -78.33%-2.42M | 72.70%-4.31M | 24.03%-2.05M | 42.29%-1.09M |
Cash from discontinued financing activities | 0 | 0 | 0 | 0 | 0 | 80.87%-574K | 0 | 0 | -249K | -325K |
Financing cash flow | 97.20%-4.96M | -237.28%-5.57M | 41.70%-5.43M | 101.35%2.21M | 144.21%3.83M | -379.11%-177.38M | 138.75%4.06M | -104.16%-9.31M | -1,371.68%-163.46M | 20.44%-8.66M |
Net cash flow | ||||||||||
Beginning cash position | -48.53%8.31M | 332.85%22.23M | 87.09%16.76M | -21.35%13.34M | -48.53%8.31M | -21.02%16.14M | -63.52%5.14M | -42.72%8.96M | -33.13%16.96M | -21.02%16.14M |
Current changes in cash | 191.87%7.19M | -312.24%-6.73M | 243.08%5.47M | 142.75%3.42M | 511.54%5.03M | -82.33%-7.83M | 54.01%3.17M | -144.91%-3.82M | 17.73%-8M | -83.32%823K |
End cash Position | 86.60%15.5M | 86.60%15.5M | 332.85%22.23M | 87.09%16.76M | -21.35%13.34M | -48.53%8.31M | -48.53%8.31M | -63.52%5.14M | -42.72%8.96M | -33.13%16.96M |
Free cash flow | 28.00%4.11M | -224.80%-4.36M | 28.39%7.05M | 102.04%214K | -87.37%1.2M | -88.73%3.21M | -110.69%-1.34M | 82.36%5.49M | -255.83%-10.47M | -39.80%9.52M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |